BNP Paribas Financial Markets Boosts Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

BNP Paribas Financial Markets grew its position in Utah Medical Products, Inc. (NASDAQ:UTMD) by 102.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,117 shares of the medical instruments supplier’s stock after purchasing an additional 566 shares during the quarter. BNP Paribas Financial Markets’ holdings in Utah Medical Products were worth $75,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the business. Bank of New York Mellon Corp grew its stake in Utah Medical Products by 2.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 49,604 shares of the medical instruments supplier’s stock worth $3,314,000 after buying an additional 1,391 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new stake in Utah Medical Products in the second quarter worth about $83,000. Kings Path Partners LLC purchased a new stake in shares of Utah Medical Products during the second quarter worth about $568,000. Rhumbline Advisers increased its holdings in shares of Utah Medical Products by 17.3% during the second quarter. Rhumbline Advisers now owns 5,508 shares of the medical instruments supplier’s stock valued at $368,000 after acquiring an additional 812 shares in the last quarter. Finally, Victory Capital Management Inc. raised its position in shares of Utah Medical Products by 124.4% in the 2nd quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier’s stock valued at $179,000 after purchasing an additional 1,482 shares during the last quarter. 69.60% of the stock is owned by institutional investors and hedge funds.

Utah Medical Products Price Performance

NASDAQ UTMD opened at $62.08 on Friday. The company has a market cap of $210.58 million, a price-to-earnings ratio of 14.54 and a beta of 0.08. The stock’s fifty day moving average price is $64.99 and its 200 day moving average price is $66.64. Utah Medical Products, Inc. has a 1 year low of $61.48 and a 1 year high of $87.00.

Utah Medical Products Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Stockholders of record on Monday, December 16th will be issued a $0.305 dividend. The ex-dividend date of this dividend is Monday, December 16th. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a dividend yield of 1.97%. Utah Medical Products’s dividend payout ratio is currently 28.57%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.